Siroon Bekkering, theme Vascular Damage, postdoc at both the Radboudumc, Dept. of Internal medicine, and the Royal Children's Hospital in Melbourne, is the winner of the Dutch National Postdoc Prize 2019.
"Bekkerings research has led to a revolution in thinking about the immune system. Her innovative research, entrepreneurship and international activities make it the persuasive winner of the National Postdoc Prize 2019", writes the jury in its report.
At the award ceremony 16 March 2019, Siroon Bekkering will receive € 10,000 and a certificate. She will use the prize money for her follow-up research into the memory of the innate immune system of patients with cardiovascular diseases. "There is still much undiscovered and much more to be discovered, and I would like to expand my own line of research in this area".
Related news items
COVID-19 associated coagulopathy - lessons after 1 year17 May 2021
Jenneke Leentjens, Saskia Middeldorp, and colleagues, published a review on the current knowledge of COVID-19 associated coagulopathy and the role of antithrombotic therapies in the Lancet Haematology.read more
Set7 regulates enhanced cytokine production in trained immunity in vitro28 April 2020
Postdoc Sam Keating and colleagues from the group of Niels Riksen, theme Vascular damage, revealed Set7 as a key regulator of trained immunity. They have published their findings in Cell Reports.read more
Catecholamines induce trained immunity in monocytes in vitro and in vivo10 April 2020
Niels Riksen and colleagues contributed data in Circulation Research, to the understanding of pathways driving inflammatory changes in conditions characterized by high catecholamine levels, and proposed that trained immunity underlies the increased cardiovascular event rate in PHEO patients.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provide a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more